Post-Birth sugar check reveals hidden diabetes risk in moms
NCT ID NCT01839448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 500 women who had gestational diabetes during pregnancy. They took a glucose test 4 to 12 weeks after giving birth to see how many had type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose. The goal was to compare women diagnosed with gestational diabetes before 24 weeks of pregnancy versus those diagnosed after 24 weeks. The study does not test a treatment but aims to improve understanding of postpartum diabetes risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better understand when to screen for diabetes after pregnancy, leading to earlier detection and prevention of type 2 diabetes.
What could go wrong
This is an observational study, not a treatment trial. It only measures outcomes without testing any intervention, so it cannot directly improve health. Results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH d'Arles - Hôpital Joseph Imbert
Arles, 13637, France
-
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, 34295, France
-
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, 34295, France
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France